Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Soteria Biotherapeutics

Request full access
San Mateo, United StatesFounded 2018Biotech & Life Sciences

About Soteria Biotherapeutics

Soteria Biotherapeutics is a biotechnology startup operating in the immuno-oncology sector. The company's primary focus is the development of a new generation of bispecific T-cell engagers, a type of cancer treatment. This innovative approach aims to treat patients with solid tumor cancers by harnessing the body's natural immune system to combat the disease.

Bispecific T-cell engagers are a class of artificial proteins that are designed to direct the body's T cells (a type of white blood cell that is key to immune responses) to kill cancer cells. Soteria's unique T-LITE™ platform provides switchable activation of these therapies, which means they can be turned on and off. This allows for safer and more effective treatments through pulsatile activity (periods of activity followed by periods of rest), reduced side effects, and the ability to administer higher doses.

The company's business model revolves around the development and commercialization of these therapies. They aim to generate revenue through the successful development, regulatory approval, and subsequent sales of their products. Their target market is primarily patients suffering from solid tumor cancers, a group that represents a significant portion of the overall cancer patient population.

In summary, Soteria Biotherapeutics is a promising startup in the immuno-oncology space, leveraging innovative technology to develop safer and more effective cancer treatments. Their unique approach to harnessing the body's immune system to fight cancer could potentially transform the lives of many patients.

Source: Dealroom company data

At a glance

Status
Operational
Employees
2
Open positions
None listed
Dealroom signal
57.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2021 $42M $168M Alexandria Venture Investments · Novartis Venture Fund · M Ventures · 5AM Ventures —
SPINOUT✓Other financing Apr 2018 $0 — University of California, San Francisco —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Soteria Biotherapeutics website traffic

Latest recorded traffic for Soteria Biotherapeutics is 50 monthly website visits, down 91.5% over the last three months. Soteria Biotherapeutics's team declined 33.3% over the past year.

Latest monthly visits50 3-month web change-91.5% 1-year team growth-33.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Soteria Biotherapeutics in the San Mateo ecosystem

Live from Dealroom

The Soteria Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • 5AM Ventures
  • Roche Venture Fund
  • Alexandria Venture Investments
  • Novartis Venture Fund
  • M Ventures

Other known investors3 additional known investors

Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Soteria Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Soteria Biotherapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.